Zui Tan

724 total citations · 1 hit paper
23 papers, 531 citations indexed

About

Zui Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Zui Tan has authored 23 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Zui Tan's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Zui Tan is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Zui Tan collaborates with scholars based in China and United States. Zui Tan's co-authors include Hongyao Liu, Tinghong Ye, Cailing Gan, Yuting Xie, Taixiong Xue, Yuqin Yao, Hongbao Sun, Xingyu Qiu, Di Wang and Chuan Liang and has published in prestigious journals such as Journal of Neuroscience, European Journal of Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

Zui Tan

23 papers receiving 528 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

2021 153 citations Zui Tan, Hongbao Sun et al. Frontiers in Cell and Developmental Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zui Tan China	13	196	125	123	109	61	23	531
Hongli Song China	13	285 1.5×	92 0.7×	115 0.9×	88 0.8×	57 0.9×	25	597
Frédérique Monier France	9	212 1.1×	185 1.5×	37 0.3×	175 1.6×	112 1.8×	12	624
Xueling Cui China	15	382 1.9×	61 0.5×	40 0.3×	43 0.4×	84 1.4×	41	631
Byung Sup Kim South Korea	16	167 0.9×	99 0.8×	247 2.0×	27 0.2×	180 3.0×	55	942
Min Young Park South Korea	9	154 0.8×	111 0.9×	82 0.7×	19 0.2×	41 0.7×	25	539
Jèssica Mainez Spain	7	280 1.4×	75 0.6×	53 0.4×	117 1.1×	225 3.7×	9	563
George K. Turi United States	12	225 1.1×	182 1.5×	192 1.6×	75 0.7×	97 1.6×	25	607
Mingliang Lu China	10	281 1.4×	29 0.2×	110 0.9×	35 0.3×	98 1.6×	22	711
Maria Luisa Barretta Italy	13	257 1.3×	78 0.6×	86 0.7×	53 0.5×	179 2.9×	26	707
Angela Michelucci Italy	14	207 1.1×	39 0.3×	283 2.3×	35 0.3×	224 3.7×	43	672

Countries citing papers authored by Zui Tan

Since Specialization

Citations

This map shows the geographic impact of Zui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zui Tan more than expected).

Fields of papers citing papers by Zui Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zui Tan. The network helps show where Zui Tan may publish in the future.

Co-authorship network of co-authors of Zui Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Zui Tan. A scholar is included among the top collaborators of Zui Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zui Tan. Zui Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Yue, Zui Tan, Wei Wei, et al.. (2025). Design, synthesis, and biological evaluation of a potent and orally bioavailable FGFRs inhibitor for fibrotic treatment. European Journal of Medicinal Chemistry. 285. 117232–117232. 2 indexed citations

Gan, Cailing, Yan Wang, Zhongzheng Xiang, et al.. (2022). Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro. Journal of Advanced Research. 51. 109–120. 27 indexed citations

Lin, Yue, Taixiong Xue, Zhihao Liu, et al.. (2022). Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents. European Journal of Medicinal Chemistry. 242. 114685–114685. 7 indexed citations

Tan, Zui, Guan Wang, Zhihao Liu, et al.. (2022). Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis. European Journal of Medicinal Chemistry. 245(Pt 2). 114918–114918. 9 indexed citations

Gan, Cailing, Qianyu Zhang, Hongyao Liu, et al.. (2022). Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study. Respiratory Research. 23(1). 32–32. 23 indexed citations

Xue, Taixiong, Yue Lin, Guonian Zhu, et al.. (2022). An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF‐β1 signalling. Liver International. 43(3). 718–732. 8 indexed citations

Tan, Zui, Hongbao Sun, Taixiong Xue, et al.. (2021). Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. Frontiers in Cell and Developmental Biology. 9. 730176–730176. 153 indexed citations breakdown →

Xue, Taixiong, Xingyu Qiu, Hongyao Liu, et al.. (2021). Epigenetic regulation in fibrosis progress. Pharmacological Research. 173. 105910–105910. 73 indexed citations

Liu, Hongyao, Xiuli Wu, Cailing Gan, et al.. (2021). A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models. Cell Proliferation. 54(7). e13081–e13081. 20 indexed citations

10.

Wu, Sisi, et al.. (2020). Hemangiopericytoma: Incidence, Treatment, and Prognosis Analysis Based on SEER Database. BioMed Research International. 2020(1). 2468320–2468320. 16 indexed citations

11.

Wu, Yun, Huijun Chen, Zui Tan, Dan Li, & Chuan Liang. (2019). Therapeutic effects of Erbin inhibitor on spinal cord contusion in mice.. PubMed. 11(4). 2570–2579. 4 indexed citations

12.

Tan, Zui, et al.. (2016). A moments-based algorithm for optimizing the information mined in post-processing spray images. Experiments in Fluids. 57(2). 35 indexed citations

13.

Chen, Tao, et al.. (2014). Netrin-1 with stem cells promote angiogenesis in limb ischemic rats. Journal of Surgical Research. 192(2). 664–669. 14 indexed citations

14.

Tan, Zui, et al.. (2013). Construction and expression of D-dimer and GPIIb/IIIa single-chain bispecific antibody. Experimental and Therapeutic Medicine. 6(2). 552–556. 3 indexed citations

15.

Liang, Chuan, Yanmei Tao, Chengyong Shen, et al.. (2012). Erbin Is Required for Myelination in Regenerated Axons after Injury. Journal of Neuroscience. 32(43). 15169–15180. 37 indexed citations

16.

Xia, Hongli, et al.. (2011). Production of monoclonal anti-GP II b/IIIa scFv antibodies from scFv phage libraries. Zhonghua shiyan waike zazhi. 28(4). 529–532. 1 indexed citations

17.

Xia, Hongli, et al.. (2011). Isolation of specific humanized anti-D-dimer scFv fragments from scFv phage libraries. Zhonghua weishengwuxue he mianyixue zazhi. 31(2). 168–172. 1 indexed citations

18.

Liu, Jun, et al.. (2009). KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway. Molecular and Cellular Biochemistry. 335(1-2). 29–35. 24 indexed citations

19.

Chen, Feng, et al.. (2007). Combination of VEGF165/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization. European Journal of Pharmacology. 568(1-3). 222–230. 22 indexed citations

20.

Chen, Feng, et al.. (2007). Adeno-associated virus vectors simultaneously encoding VEGF and angiopoietin-1 enhances neovascularization in ischemic rabbit hind-limbs. Acta Pharmacologica Sinica. 28(4). 493–502. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact